Best Practices for Biosafety Risk Assessment during Vaccine Production

  • By: Staff Editor
  • Date: September 30, 2011
Webinar All Access Pass Subscription Abstract:

A vaccine is a biological preparation that provides immunity against a particular disease. It is usually made of dead or weakened organisms which cause the particular disease. Biosafety means the safe handling of infectious biological materials which can cause diseases. Biosafety level refers to safety tiers prescribed by the Center for Disease Control (CDC), a United States Federal Agency, for laboratories which work with infectious materials. 

This article discusses how to comply with biosafety risk assessment requirements during vaccine production.

Bookmark and Share
Best Sellers
You Recently Viewed